These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3587578)

  • 1. Dexamethasone suppression test and MMPI scales.
    Ansseau M; von Frenckell R; Franck G; Geenen V; Legros JJ
    Neuropsychobiology; 1986; 16(2-3):68-71. PubMed ID: 3587578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPI, personality dysfunction and the dexamethasone suppression test in major depression.
    Norman WH; Keitner GI; Miller IW
    J Affect Disord; 1985 Jul; 9(1):97-101. PubMed ID: 3160753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cortisol and depression in pathological gamblers.
    Ramirez LF; McCormick RA; Lowy MT
    Br J Psychiatry; 1988 Nov; 153():684-6. PubMed ID: 3255458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dexamethasone suppression test in daily chronic headache sufferers.
    Martignoni E; Facchinetti F; Manzoni GC; Petraglia F; Nappi G; Genazzani AR
    Psychiatry Res; 1986 Sep; 19(1):51-7. PubMed ID: 3786599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathological correlates of dopaminergic disturbances in major depression.
    Pitchot W; Hansenne M; Moreno AG; von Frenckell R; Ansseau M
    Neuropsychobiology; 1990-1991; 24(4):169-72. PubMed ID: 2135707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some neurovegetative correlates of Minnesota Multiphasic Personality Inventory (MMPI).
    Bonanni Rey RA; Guinjoan SM; Cardinali DP
    Acta Physiol Pharmacol Ther Latinoam; 1992; 42(4):147-53. PubMed ID: 1364236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.
    Mendlewicz J; Hubain PP; Koumakis C
    Neuropsychobiology; 1984; 12(1):23-6. PubMed ID: 6514175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test and coping behavior in psychosocial stress.
    Frecska E; Lukács H; Arató M; Mód L; Alföldi A; Magyar I
    Psychiatry Res; 1988 Feb; 23(2):137-45. PubMed ID: 3363022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between age and post-dexamethasone cortisol: a test of three hypotheses.
    Stangl D; Pfohl B; Zimmerman M; Coryell W; Corenthal C
    J Affect Disord; 1986; 11(3):185-97. PubMed ID: 2951406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma dexamethasone and cortisol levels in depressed outpatients.
    Asnis GM; Friedman JM; Miller AH; Iqbal N; Lo ES; Cooper TB; Halbreich U; Lemus CZ; van Praag HM; Rubinson E
    J Affect Disord; 1989; 16(1):5-10. PubMed ID: 2521652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
    Devanand DP; Decina P; Sackeim HA; Hopkins N; Novacenko H; Malitz S
    Biol Psychiatry; 1987 Apr; 22(4):463-72. PubMed ID: 3567261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation between morning plasma cortisol levels and MMPI psychasthenia and depression scale scores in victims of mobbing with adjustment disorders.
    Rocco A; Martocchia A; Frugoni P; Baldini R; Sani G; Di Simone Di Giuseppe B; Vairano A; Girardi P; Monaco E; Tatarelli R; Falaschi P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):610-3. PubMed ID: 17984936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and behavioural responses to methylphenidate in depression.
    Joyce PR; Donald RA; Nicholls MG; Livesey JH; Abbott RM
    Psychol Med; 1986 Aug; 16(3):531-40. PubMed ID: 3763771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dexamethasone suppression test and endogenous components of evoked potentials in depressed subjects].
    Pholien P; Charles G; Tilmant JJ; Wilmotte J
    Acta Psychiatr Belg; 1987; 87():694-703. PubMed ID: 3452988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of stress in interpreting the dexamethasone suppression test.
    Blouin J; Spindler E; Perez E; Blouin A; Hotz S; Hakkaku J
    Can J Psychiatry; 1992 Dec; 37(10):724-7. PubMed ID: 1473078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.